03-Nov-2026 19:05:40

AARTI DRUGS Q2 FY27 ; NET PROFIT UP 83% AT ₹83 CR (YOY), UP 65% (QOQ)

REVENUE UP 27% AT ₹826 CR (YOY), UP 18% (QOQ) EBITDA UP 61% AT ₹135 CR (YOY), UP 38% (QOQ) MARGINS AT 16.4% VS 12.9% (YOY), 14.0% (QOQ)

AARTI DRUGS LTD.